MedPath

A multicenter prospective observational study on the structured psychotropic drugs intervention for hyperactive delirium in terminally-ill cancer patients

Not Applicable
Conditions
Cancer
Registration Number
JPRN-UMIN000040146
Lead Sponsor
Seirei Mikatahara General Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

1) Patients for whom psychotropic drugs are contraindicated. 2) Patients who indicated that they would refuse to participate in this study. 3) Patients judged to be inappropriate by the attending physician.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The proportion of patients receiving structured psychotropic drugs intervention for hyperactive/mixed delirium at 3 days after (T2). If not, the reason for discontinuation.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath